Dysfunction of the CFTR (cystic fibrosis transmembrane conductance regulator) protein is associated with an increased risk of GI tumors, both in patients with cystic fibrosis and in sporadic GI cancers (353). The gene discussed is CFTR; the disease is digestive system neoplasm.